Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
1. Pfizer sells remaining stake in BioNTech, impacting BNTX shares negatively. 2. Block trade of 4.55 million ADAs priced $108-$111.70 could fetch $508 million. 3. BNTX reported $1.78 billion sales, beating expectations despite lower COVID vaccine sales. 4. Pfizer's sales decreased due to COVID product revenue drop, affecting market sentiment.